Key result
Postmenopausal women with nighttime hypertension had significantly lower endothelial function compared to those with normal nighttime systolic blood pressure (mean FMD 2.95% vs 5.52%; P=0.002).
Why the study?
Is nighttime hypertension associated with reduced endothelial function in postmenopausal women?
Cross-Sectional (n=100)
Is nighttime hypertension associated with reduced endothelial function in postmenopausal women?
Absolute Event Rate: 2.95% vs 5.52%
p-value: p=0.002
Nighttime hypertension in postmenopausal women is associated with significantly reduced endothelial function, suggesting a potential mechanism for their increased cardiovascular risk.
Nighttime hypertension linked to endothelial dysfunction in postmenopausal women; leaves open whether BP control improves vascular outcomes.
OBJECTIVE: Hypertension becomes more prevalent in women during their postmenopausal years. Nighttime systolic blood pressure (SBP) is especially predictive of adverse cardiac events, and the relationship between rising nighttime SBP and cardiovascular risk increases more rapidly in women compared with men. The reasons for the prognostic significance of nighttime SBP are not completely known but may involve vascular endothelial dysfunction. The purposes of this study were to examine the relationship between nighttime SBP and endothelial function, as assessed by brachial artery flow-mediated dilation (FMD), and to determine whether postmenopausal women with nighttime hypertension (SBP ≥120 mm Hg) evidenced greater endothelial dysfunction compared with women with normal nighttime SBP. METHODS: One hundred postmenopausal women (mean [SD] age, 65.8 [7.5] y; mean [SD] body mass index, 28.3 [4.7] kg/m; hypertension, 47%; coronary artery disease, 51%; mean [SD] clinic SBP, 137 [17] mm Hg; mean [SD] clinic diastolic blood pressure, 67 [11] mm Hg; nighttime hypertension, 34 women) underwent 24-hour ambulatory blood pressure monitoring, actigraphy, and brachial artery FMD assessment. RESULTS: Multivariate regression models showed that higher nighttime SBP and larger baseline artery diameter were inversely related to FMD. Nighttime SBP and baseline artery diameter accounted for 23% of the variance in FMD. After adjustment for baseline artery diameter, women with nighttime hypertension had lower mean (SD) FMD than women with normal nighttime SBP (2.95% [0.65%] vs 5.52% [0.46%], P = 0.002). CONCLUSIONS: Nighttime hypertension is associated with reduced endothelial function in postmenopausal women. Research examining the therapeutic benefits of nighttime hypertension treatment on endothelial function and future cardiovascular risk in postmenopausal women is warranted.
No takes yet. Share an insight, caveat, or question.
Routledge et al. (2015) conducted a cross-sectional in Nighttime systolic hypertension (n=100). Nighttime hypertension (SBP ≥120 mm Hg) vs. Normal nighttime SBP was evaluated on Endothelial function assessed by brachial artery flow-mediated dilation (FMD) (p=0.002). Postmenopausal women with nighttime hypertension had significantly lower endothelial function compared to those with normal nighttime systolic blood pressure (mean FMD 2.95% vs 5.52%; P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: